Scalp Cooling and Chemotherapy-Induced Alopecia: Evaluating Cost-Effectiveness and Insurance Coverage
January 2026
in “
Dermatology Online Journal
”
Studysummary This study analyzed the cost-effectiveness of scalp cooling as a means of preventing chemotherapy-induced hair loss and found it to be financially reasonable compared to dermatologic management strategies, suggesting that it should be considered for routine insurance coverage due to its cost-effectiveness.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on doj.dermsquared.com →